Valarie Denise Kelly, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 5639 Lewis B Puller Hwy, Shacklefords, VA 23156 Phone: 804-785-2096 |
News Archive
The Medicines Company today announced the publication of the results from the SOLO I Phase 3 clinical trial of ORBACTIV (oritavancin), an investigational intravenous antibiotic treatment for Acute Bacterial Skin and Skin Structure Infections (ABSSSI), in the New England Journal of Medicine.
A new evidence-based map estimates that in 2009 2.85 billion people lived "at risk of infection" with the malaria parasite Plasmodium vivax, BMJ News reports. As described in a study, published Tuesday in PLoS Neglected Tropical Diseases, P vivax "is more widespread and potentially represents a greater burden on human health in some parts of the world than P falciparum, the species usually associated with the greatest mortality and morbidity," BMJ News writes (Moszynski, 8/3).
Cardiogenesis Corporation, released comments today regarding the STAR-heart study.The STAR-heart study, which was presented at the European Society of Cardiology 2010 Congress in August 2010, reported that the intracoronary injection of autologous stem cells derived from bone marrow is associated with improved hemodynamics and long term survival in the treatment of chronic heart failure.
Total Medical Solutions (TMS) made Inc. Magazine's top 5,000 fastest growing private companies in the country, coming in as the 15th fastest growing firm in Florida and among the top five in the Orlando market. The Inc. 5000 is ranked according to percentage revenue growth from 2005 through 2008.
The study, which looked at Medicare records of more than 130,000 women, found that those who underwent the faster treatment, called brachytherapy, were about twice as likely to have a mastectomy in the following five years -;
› Verified 4 days ago